Skip to main content
. 2010 Aug 24;103(6):772–775. doi: 10.1038/sj.bjc.6605828

Table 1. Clinical characteristics and details of treatments (70 patients).

Median age (min–max) 54 years (32–74)
Treatment setting
 Neoadjuvant 6
 Adjuvant 12
 Metastatic 52
   
Number of previous lines of chemotherapy
 0 12
 1 27
 ⩾2 13
   
Regimen
Sequential anthracyclin/docetaxel + concomitant Bevacizumab
  Neo adjuvant treatment 6
  Adjuvant treatment 12
 Docetaxel/Bevacizumab 37
 Paclitaxel/Bevacizumab 14
 Capecitabine/Bevacizumab 1
Bevacizumab as maintenance treatment 14